Using Plants As A Source Of Anti – Cancer Compounds For Undergraduate Research Experiences – Dr Patrick Still, California State University, Dominguez Hills
Original Article Reference
This SciPod is a summary of
https://doi.org/10.33548/SCIENTIA569
Share Episode
About this episode
Cancer, in all its forms, is one of the major causes of death across the world and we are in urgent need of more effective interventions for this global killer. Drugs used to treat diseases like cancer can be either synthetic in origin, semi-synthetic derivatives of natural products, or unmodified natural products. Dr Patrick Still and his team at California State University, Dominguez Hills (CSUDH), conduct research to identify and biologically screen anti-cancer compounds derived specifically from plant materials. Studies involving structure elucidation and biological testing of compounds from plants have provided undergraduate research experiences for students across chemical and biological sciences majors on the CSUDH campus.
This work is licensed under a Creative Commons Attribution 4.0 International License.
What does this mean?
Share: You can copy and redistribute the material in any medium or format
Adapt: You can change, and build upon the material for any purpose, even commercially.
Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
More episodes
Professor Magnus S. Magnusson | The surprising similarities between the structures of human cells and societies
Research by Professor Magnus S. Magnusson at the University of Iceland demonstrates surprising similarities between the organization of cellular protein networks and of human societies. He reveals how the invention of writing and, very recently, general education, transformed human civilization in ways that mirror ancient biological developments and emphasises how this makes humans unique.
Dr. Roberta Martinelli | Sepsis and the Silent Battle Within: Neutrophils’ Role in Sepsis-Related Complications
Sepsis is a critical illness that begins with a simple infection and degenerates into a severe and dysregulated immune response that affects the whole body. This significant immune reaction typically causes widespread inflammation and can progress very rapidly. This can result in serious damage to tissues and organs, potentially leading to organ failure and death. Despite the severity of sepsis and its frequent poor prognosis, effective treatments are still elusive, and many sepsis patients remain at high risk of death and serious complications. Part of the issue is the complex cascade of cellular and biochemical events that underlie sepsis, which has made it difficult to obtain a comprehensive overview of the illness from which to design an effective treatment. Dr. Roberta Martinelli, Executive Director of Stromal Immunology and Early Discovery, Discovery Immunology, Merck, and colleagues, have published a study in the journal iScience which reveals new insights into the complex biological milieu underlying sepsis, and uncovers pathways and potential treatment targets that could change how we diagnose and treat this life-threatening illness.
Dr. Allen Place | Small but Deadly: The Tale of K. veneficum
The oceans, huge and brimming with diverse lifeforms, pose no less a struggle for survival for their inhabitants than that faced by creatures on dry land. Evolution has furnished marine organisms with huge array of defensive, and indeed, offensive adaptations to help them to thrive in this battleground. Among the organisms who live and compete in the ocean are dinoflagellates. These are small, single-celled creatures that are an important component of plankton found in marine ecosystems. Despite their tiny size, dinoflagellates such as Karlodinium veneficum can wield potent biochemical weaponry that gives them an edge against other competing organisms. Decades since the discovery of the toxic properties of Karlodinium veneficum, researchers such as Dr. Allen Place of the University of Maryland Center for Environmental Sciences, and his colleagues, have begun to unravel the secrets of its potent toxins, called karlotoxins. Their findings offer fascinating insights into the interactions of marine life and the weapons they adopt to capture prey and deter predators.
Dr. Andrea Grindeland | The Tiny Heroes That Could Save Deer and Elk from Chronic Wasting Disease
It’s not difficult to picture a lush forest landscape populated with majestic deer and elk, long admired for their prowess and strength. Now, imagine that same scene, but instead of healthy and happy animals browsing a forest ecosystem, we see creatures that are thin and disoriented, that struggle to run or even stand, with halting and confused movements that are pitiable and distressing to watch. This is the harsh reality of Chronic Wasting Disease, an illness that currently has no cure and that threatens such wildlife around the world. Part of the challenge with Chronic Wasting Disease is the difficulty in studying it reliably in wildlife. The disease has subtle signs at an early stage, and it is difficult to obtain robust and reproducible data from large, wild animals who often live in remote and poorly accessible forest ecosystems. Consequently, researchers have turned to an unlikely but powerful ally, the tiny laboratory mouse, to model and study the disease under laboratory conditions. Dr. Andrea Grindeland of the McLaughlin Research Institute, and her colleagues, have authored a review of the existing mouse models of Chronic Wasting Disease. These tiny creatures have been engineered to mimic the biology of cervids, such as deer and elk, and are providing crucial insights into how Chronic Wasting Disease evolves, is transmitted, and how it might one day be controlled or even eradicated.
Increase the impact of your research
• Good science communication encourages everyday people to be scientifically literate so that they can analyse the integrity and legitimacy of information.
• Good science communication encourages people into STEM-related fields of study and employment.
• Good public science communication fosters a community around research that includes both members of the public, policymakers and scientists.
• In a recent survey, 75% of people suggested they would prefer to listen to an interesting story than read it.
Step 2 SciPod script written
Step 3 Voice audio recorded
Step 4 SciPod published